Meta Information
ID:shilajit
Name:Shilajit
Schema Version:2.4_uniform_evidence_2026_06_18
Created
2026-07-02T07:04:56Z
Model
phase-b-newfiles-claude-opus-4.8
Interactions
Target id:
/condition/hemochromatosis
Target name:
Iron overload / hemochromatosis
Severity:
moderate
Interaction type:
adverse
Nature:
conditional
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Shilajit contains iron and other minerals, which can worsen iron overload conditions.
Actionable advice:
Shilajit is best avoided with hemochromatosis or iron overload.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Shilajit provides bioavailable iron/minerals; harmful in iron-overload states. Mechanistic.
Label source:
Class inference
Action type:
avoid
Target id:
/class/antidiabetic-medications
Target name:
Antidiabetic medications
Severity:
minor
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Shilajit may modestly lower blood glucose.
Actionable advice:
It is a good idea to check glucose if combining.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Mild glucose-lowering activity; low-certainty.
Label source:
Class inference
Action type:
monitor